• Study on the Effectiveness and Safety of CAEL-101 with Plasma Cell Dyscrasia Treatment in Patients with Stage IIIa AL Amyloidosis

    Not recruiting

    3 1 1
    Investigated Diseases:
    Austria Czechia France Germany Greece Italy +2
  • Study on Semaglutide for Achieving Sinus Rhythm in Patients with Obesity and Persistent Atrial Fibrillation

    Not recruiting

    3 1
    Investigated Diseases:
    Investigated Drugs:
    The Netherlands
  • Study on the Effectiveness and Safety of Depemokimab vs. Mepolizumab for Adults with Relapsing or Refractory Eosinophilic Granulomatosis with Polyangiitis

    Not recruiting

    3 1 1
    Investigated Drugs:
    Austria Belgium France Germany Hungary Italy +5
  • Study on the Effectiveness of Lutetium (177Lu) Oxodotreotide and Octreotide in Patients with Advanced GEP-NET Tumors (Grade 2 and 3)

    Not recruiting

    3 1 1 1
    France Germany Italy The Netherlands Spain
  • Study on the Safety and Effects of Trastuzumab Deruxtecan with Drug Combination for Patients with HER2-positive Metastatic Breast Cancer

    Not recruiting

    1 1 1 1
    Investigated Diseases:
    Germany Italy Poland Spain
  • Study on 5-Fluorouracil and Calcipotriol for Treating Actinic Keratosis in Patients

    Not recruiting

    3 1 1 1
    Investigated Diseases:
    Investigated Drugs:
    The Netherlands
  • Study of KarXT (trospium chloride and xanomeline tartrate) in patients with inadequately controlled schizophrenia symptoms

    Not recruiting

    3 1
    Investigated Diseases:
    Bulgaria
  • Study on the Effects of Obeticholic Acid and Bezafibrate for Patients with Primary Biliary Cholangitis Who Cannot Tolerate Ursodeoxycholic Acid

    Not recruiting

    2 1 1
    Belgium Croatia Czechia Estonia France Germany +6
  • Study on the Effects of EVX-01 and Pembrolizumab in Adults with Advanced Melanoma

    Not recruiting

    2 1 1 1
    Investigated Diseases:
    Investigated Drugs:
    Italy
  • Study on Asciminib and Asciminib Hydrochloride for Patients with Chronic Myelogenous Leukemia in Chronic Phase After Two or More Tyrosine Kinase Inhibitors

    Not recruiting

    3 1 1 1
    Investigated Diseases:
    Austria France Germany Greece Italy Poland +1

powered by